Effectiveness of occupational therapy in Parkinson’s disease: study protocol for a randomized controlled trial

Trials

Marten Munneke²  Bastiaan R Bloem¹  Maria WG Nijhuis-van der Sanden⁵  Eddy MM Adang³  George F Borm³  Maud J Graff⁵  Ingrid HWM Sturkenboom⁴ 

[1] Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;Nijmegen Centre of Evidence Based Practice, Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;Nijmegen Centre of Evidence Based Practice, Department of Rehabilitation-Occupational Therapy (898), Radboud University Nijmegen Medical Centre, Reinier Postlaan 2, 6525GC, PO Box 9101, 6500HB, Nijmegen, The Netherlands;Nijmegen Centre of Evidence Based Practice, Scientific Institute for Quality of Healthcare, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

关键词: Economic evaluation;    Effectiveness;    Study protocol;    Randomized controlled trial;    caregiver;    Guidelines;    Occupational therapy;    Parkinson disease;   

Others  :  1094848
DOI  :  10.1186/1745-6215-14-34

 received in 2012-10-31, accepted in 2013-01-11,  发布年份 2013

【 摘 要 】

Background

Occupational therapists may have an added value in the care of patients with Parkinson’s disease whose daily functioning is compromised, as well as for their immediate caregivers. Evidence for this added value is inconclusive due to a lack of rigorous studies. The aim of this trial is to evaluate the (cost) effectiveness of occupational therapy in improving daily functioning of patients with Parkinson’s disease.

Methods/Design

A multicenter, assessor-blinded, two-armed randomized controlled clinical trial will be conducted, with evaluations at three and six months. One hundred ninety-two home-dwelling patients with Parkinson’s disease and with an occupational therapy indication will be assigned to the experimental group or to the control group (2:1). Patients and their caregivers in the experimental group will receive ten weeks of home-based occupational therapy according to recent Dutch guidelines. The intervention will be delivered by occupational therapists who have been specifically trained to treat patients according to these guidelines. Participants in the control group will not receive occupational therapy during the study period. The primary outcome for the patient is self-perceived daily functioning at three months, assessed with the Canadian Occupational Performance Measure. Secondary patient-related outcomes include: objective performance of daily activities, self-perceived satisfaction with performance in daily activities, participation, impact of fatigue, proactive coping skills, health-related quality of life, overall quality of life, health-related costs, and effectiveness at six months. All outcomes at the caregiver level will be secondary and will include self-perceived burden of care, objective burden of care, proactive coping skills, overall quality of life, and care-related costs. Effectiveness will be evaluated using a covariance analysis of the difference in outcome at three months. An economic evaluation from a societal perspective will be conducted, as well as a process evaluation.

Discussion

This is the first large-scale trial specifically evaluating occupational therapy in Parkinson’s disease. It is expected to generate important new information about the possible added value of occupational therapy on daily functioning of patients with Parkinson’s disease.

Trial registration

Clinicaltrials.gov: NCT01336127.

【 授权许可】

   
2013 Sturkenboom et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, Weiner WJ: The evolution of disability in Parkinson disease. Mov Disord 2008, 23:790-796.
• [2]Martignoni E, Citterio A, Zangaglia R, Godi L, Pacchetti C, Fundaro C, Corengia E, Bono G, Nappi G: How parkinsonism influences life: the patients' point of view. Neurol Sci 2011, 32:125-131.
• [3]Foster ER, Hershey T: Everyday executive function is associated with activity participation in Parkinson disease without dementia. OTJR 2011, 31:16-22.
• [4]Dowding CH, Shenton CL, Salek SS: A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging 2006, 23:693-721.
• [5]Global Parkinson's disease Survey Steering Committee: Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002, 17:60-67.
• [6]Martinez-Martin P, Benito-Leon J, Alonso F, Catalan MJ, Pondal M, Zamarbide I, Tobias A, de Pedro J: Quality of life of caregivers in Parkinson's disease. Qual Life Res 2005, 14:463-472.
• [7]van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR: Moving towards patient-centered healthcare for patients with Parkinson's disease. Parkinsonism Relat Disord 2011, 17:360-364.
• [8]van der Marck MA, Kalf JG, Sturkenboom IH, Nijkrake MJ, Munneke M, Bloem BR: Multidisciplinary care for patients with Parkinson's disease. Parkinsonism Relat Disord 2009, Suppl 3:S219-S223.
• [9]Grosset KA, Grosset DG: Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Mov Disord 2005, 20:616-619.
• [10]Gage H, Storey L: Rehabilitation for Parkinson's disease: a systematic review of available evidence. Clin Rehabil 2004, 18:463-482.
• [11]Dixon L, Duncan D, Johnson P, Kirkby L, O'Connell H, Taylor H, Deane KHO: Occupational therapy for patients with Parkinson's disease. Cochrane Database Syst Rev 2007, 3:CD002813.
• [12]Rao AK: Enabling functional independence in Parkinson's disease: update on occupational therapy intervention. Mov Disord 2010, Suppl 1:S146-S151.
• [13]Ellis T, Katz DI, White DK, DePiero TJ, Hohler AD, Saint-Hilaire M: Effectiveness of an inpatient multidisciplinary rehabilitation program for people with Parkinson disease. Phys Ther 2008, 88:812-819.
• [14]Tickle-Degnen L, Ellis T, Saint-Hilaire MH, Thomas CA, Wagenaar RC: Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial. Mov Disord 2010, 25:194-204.
• [15]Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J: Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2003, 74:158-162.
• [16]Trend P, Kaye J, Gage H, Owen C, Wade D: Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers. Clin Rehabil 2002, 16:717-725.
• [17]Guo L, Jiang Y, Yatsuya H, Yoshida Y, Sakamoto J: Group education with personal rehabilitation for idiopathic Parkinson's disease. Can J Neurol Sci 2009, 36:51-59.
• [18]Sturkenboom IHWM, Thijssen MCE, Gons-van Elsacker JJ, Maasdam A, Schulten M, Vijver-Visser D, Steultjens EJM, Bloem BR, Munneke M: Ergotherapie bij de ziekte van Parkinson, een richtlijn van Ergotherapie Nederland. Utrecht/Den Haag: Ergotherapie Nederland/Uitgeverij Lemma; 2008.
• [19]Sturkenboom IHWM, Thijssen MCE, Gons-van Elsacker JJ, Maasdam A, Schulten M, Vijver-Visser D, Steultjens EJM, Bloem BR, Munneke M: Guidelines for occupational therapy in Parkinson's disease rehabilitation. Nijmegen/Miami: ParkinsonNet/NPF; 2012. [online pdf http://www.parkinson.org/Search-Pages/Search.aspx?pKeywords=guidelines webcite]
• [20]Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, Lester H, Wilson P, Kinmonth AL: Designing and evaluating complex interventions to improve health care. BMJ 2007, 334:455-459.
• [21]Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M: Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655.
• [22]Sturkenboom IH, Graff MJ, Borm GF, Veenhuizen Y, Bloem BR, Munneke M, der Sanden MW N-v: The impact of occupational therapy in Parkinson's disease: a randomized controlled feasibility study. Clin Rehabil 2012. epub ahead of print
• [23]Keus SH, Oude Nijhuis LB, Nijkrake MJ, Bloem BR, Munneke M: Improving community healthcare for patients with Parkinson's disease: the Dutch model. Parkinson’s Disease 2012, 2012:543426.
• [24]Nijkrake MJ, Keus SH, Overeem S, Oostendorp RA, Vlieland TP, Mulleners W, Hoogerwaard EM, Bloem BR, Munneke M: The ParkinsonNet concept: development, implementation and initial experience. Mov Disord 2010, 25:823-829.
• [25]Law M, Baptiste S, Carswell A: McColl M, Polatajko H, Pollock N: Canadian Occupational Performance Measure. Toronto: CAOT Publications; 2005.
• [26]Chaparro C, Ranka J: Research development. In The PRPP research training manual. Sydney: School of Occupational Therapy; 1996.
• [27]Baum C, Edwards D: Activity Card Sort. Bethesda, MD: AOTA Press; 2008.
• [28]Duncan RP, Earhart GM: Measuring participation in individuals with Parkinson disease: relationships with disease severity, quality of life, and mobility. Disabil Rehabil 2011, 33(15–16):1440-1446.
• [29]van der Zee CH, Priesterbach AR, van der Dussen L, Kap A, Schepers VP, Visser-Meily JM, Post MW: Reproducibility of three self-report participation measures: The ICF Measure of Participation and Activities Screener, the Participation Scale, and the Utrecht Scale for Evaluation of Rehabilitation-Participation. J Rehabil Med 2010, 42:752-757.
• [30]Post MW, van de Port IG, Kap B, Berdenis van Berlekom SH: Development and validation of the Utrecht Scale for Evaluation of Clinical Rehabilitation (USER). Clin Rehabil 2009, 23:909-917.
• [31]Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N: The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997, 26:353-357.
• [32]Peto V, Jenkinson C, Fitzpatrick R: Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 2001, 30:299-302.
• [33]Marinus J, Visser M, Jenkinson C, Stiggelbout AM: Evaluation of the Dutch version of the Parkinson's Disease Questionnaire 39. Parkinsonism Relat Disord 2008, 14:24-27.
• [34]Herlofson K, Larsen JP: Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale. Eur J Neurol 2002, 9:595-600.
• [35]Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A: Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord 2010, 25:805-822.
• [36]Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG: Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007, 22:1077-1092.
• [37]Zarit SH, Reever KE, Bach-Peterson J: Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980, 20:649-655.
• [38]Zigmond A, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
• [39]The EuroQol Group: EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
• [40]Bode C, Thoolen B, de Ridder D: Measuring proactive coping. Psychometric characteristics of the Utrecht Proactive Coping Competence scale (UPCC). Psychologie en Gezondheid 2008, 36:81-91.
• [41]Cup EH, op Reimer WJ S, Thijssen MC, Van Kuyk-Minis MA: Reliability and validity of the Canadian Occupational Performance Measure in stroke patients. Clin Rehabil 2003, 17:402-409.
• [42]Eyssen IC, Beelen A, Dedding C, Cardol M, Dekker J: The reproducibility of the Canadian Occupational Performance Measure. Clin Rehabil 2005, 19:888-894.
• [43]Dedding C, Cardol M, Eyssen IC, Dekker J, Beelen A: Validity of the Canadian Occupational Performance Measure: a client-centred outcome measurement. Clin Rehabil 2004, 18:660-667.
• [44]Eyssen IC, Steultjens MP, Oud TA, Bolt EM, Maasdam A, Dekker J: Responsiveness of the Canadian occupational performance measure. J Rehabil Res Dev 2011, 48:517-528.
• [45]Fahn S, Elton R: Unified Parkinson’s Disease Rating Scale. In Recent developments in Parkinson’s disease. Edited by Fahn S, Marsden C, Calne D, Goldstein M. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163. 293–304
• [46]Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
• [47]Delnoij DM, ten Asbroek G, Arah OA, de Koning JS, Stam P, Poll A, Vriens B, Schmidt P, Klazinga NS: Made in the USA: the import of American Consumer Assessment of Health Plan Surveys (CAHPS) into the Dutch social insurance system. Eur J Public Health 2006, 16:652-659.
• [48]Zuidgeest M, Sixma H, Rademakers J: Measuring patients' experiences with rheumatic care: the consumer quality index rheumatoid arthritis. Rheumatol Int 2009, 30:159-167.
• [49]Borm GF, Fransen J, Lemmens WAJG: A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol 2007, 60:1234-1238.
• [50]Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ: Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005, 149:1574-1578.
• [51]Straus ACJ: Basics of of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage; 1998.